970.8500 17.85 (1.87%)
NSE Dec 23, 2025 15:31 PM
Volume: 347.8K
 

logo
Strides Pharma Science Ltd.
24 Oct 2024, 12:00AM
970.85
1.87%
Sharekhan
Q2FY25 revenues totaling Rs. 1,201 crore, demonstrating a significant y-o-y growth rate of 20%.EBITDA stood at Rs. 236 crore, marking a remarkable y-o-y increase of 31%.
Strides Pharma has gained 38.84% in the last 1 Year
More from Strides Pharma Science Ltd.
Recommended